<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00766181</url>
  </required_header>
  <id_info>
    <org_study_id>113-03P</org_study_id>
    <nct_id>NCT00766181</nct_id>
  </id_info>
  <brief_title>Satisfaction With Pediatric Intravenous Catheter Placement in the Emergency Department</brief_title>
  <official_title>An Evaluation of Parent and Nurse Satisfaction Associated With Pediatric Peripheral Intravenous Catheter Placement Using Standard of Care vs. ZingoTM in the Emergency Department</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Anesiva, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Covance</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Anesiva, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the satisfaction among parents and nurses of
      pediatric patients with IV catheter placement in the Emergency Department.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objectives of this study are to evaluate whether the proportion of parents satisfied with
      their child's IV placement procedure is higher after the introduction of Zingo compared to
      standard of care and to evaluate changes in nursing staff satisfaction with performing IV
      placement procedures after using Zingo prior to IV placement compared to standard of care.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Product withdrawn from distribution
  </why_stopped>
  <start_date>October 2008</start_date>
  <completion_date type="Anticipated">April 2009</completion_date>
  <primary_completion_date type="Anticipated">February 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Parent's satisfaction with IV placement procedure</measure>
    <time_frame>18 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Nurse'e satisfaction with performing IV placement</measure>
    <time_frame>18 weeks</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Intravenous Placement Procedure</condition>
  <arm_group>
    <arm_group_label>1: Lifestyle</arm_group_label>
    <description>Observatonal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2: Lifestyle</arm_group_label>
    <description>Observational</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Zingo TM (lidocaine hydrochloride monohydrate) powder intradermal injection system</intervention_name>
    <description>0.5 mg lidocaine hydrochloride</description>
    <arm_group_label>2: Lifestyle</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Pediatric patients in Emergency Department requiring peripheral IV catheter placement.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  PHASE A: Parent of a pediatric patient from the age of 3 to 18 years of age who
             requires a peripheral IV placement in the Emergency Department

          -  Parent must be able to read and understand English and provide written informed
             consent

          -  Parent must be present during the IV placement

          -  PHASE B: Parent did not participate in Phase A

          -  Nurse has completed Zingo TM in-service training prior to participation

          -  Zingo is used prior to performing the IV placement procedure

        Exclusion Criteria:

        - Parent of patient with a serious unstable medical or psychological condition that would
        compromise participation in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <link>
    <url>http://www.anesiva.com/</url>
    <description>Anesiva home page</description>
  </link>
  <link>
    <url>http://www.zingo.com</url>
    <description>Zingo Product Information</description>
  </link>
  <verification_date>November 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 1, 2008</study_first_submitted>
  <study_first_submitted_qc>October 2, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 3, 2008</study_first_posted>
  <last_update_submitted>May 24, 2010</last_update_submitted>
  <last_update_submitted_qc>May 24, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 25, 2010</last_update_posted>
  <responsible_party>
    <name_title>Mitra Sadeghi, Pharm.D.</name_title>
    <organization>Anesiva, Inc.</organization>
  </responsible_party>
  <keyword>IV placement; Parent satisfaction level</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emergencies</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

